Psychiatric disorders during pregnancy

被引:20
作者
Cott, AD
Wisner, KL
机构
[1] Johns Hopkins Univ, Dept Psychiat, Baltimore, MD USA
[2] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA USA
关键词
D O I
10.1080/0954026031000136848
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Treating women with psychiatric disorders during pregnancy is a challenge for numerous reasons. Balancing the risks and benefits of symptoms and treatments is particularly important during pregnancy because both medication and maternal illness may have adverse effects on the fetus. Communication of options in the management of psychiatric disorders in pregnancy is vital to optimal treatment. One barrier to effective communication has been a paucity of research from which clinicians can draw information, particularly in the area of pharmacological treatment. However, emerging evidence points to the low risk of many psychotropic medications during pregnancy. Uncertainty must not prevent frank risk-benefit discussions from occurring between treating physicians and their pregnant patients. Psychiatrists can prepare themselves for management decisions by reviewing the current literature.
引用
收藏
页码:217 / 230
页数:14
相关论文
共 160 条
[21]   COGNITIVE THERAPY OF ANXIETY DISORDERS [J].
CHAMBLESS, DL ;
GILLIS, MM .
JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY, 1993, 61 (02) :248-260
[22]  
Chelmow D, 1997, J Matern Fetal Med, V6, P31
[23]   Omega-3 fatty acids for depression in pregnancy [J].
Chiu, CC ;
Huang, SY ;
Shen, WW ;
Su, KP .
AMERICAN JOURNAL OF PSYCHIATRY, 2003, 160 (02) :385-385
[24]   Antepartum depressive symptomatology is associated with adverse obstetric and neonatal outcomes [J].
Chung, TKH ;
Lau, TK ;
Yip, ASK ;
Chiu, HFK ;
Lee, DTS .
PSYCHOSOMATIC MEDICINE, 2001, 63 (05) :830-834
[25]   The contribution of biological factors to the pathogenesis of psychiatric disorders in the postpartum period: a survey [J].
Claes, M ;
Maes, M ;
Jacquemyn, Y .
ACTA NEUROPSYCHIATRICA, 1997, 9 (04) :128-132
[26]  
COHEN LS, 1989, J CLIN PSYCHIAT, V50, P266
[27]   Birth outcomes following prenatal exposure to fluoxetine [J].
Cohen, LS ;
Heller, VL ;
Bailey, JW ;
Grush, L ;
Ablon, JS ;
Bouffard, SM .
BIOLOGICAL PSYCHIATRY, 2000, 48 (10) :996-1000
[28]  
COHEN LS, 1995, AM J PSYCHIAT, V152, P1641
[29]  
Cohen LS, 1998, J CLIN PSYCHIAT, V59, P18
[30]   A REEVALUATION OF RISK OF IN-UTERO EXPOSURE TO LITHIUM [J].
COHEN, LS ;
FRIEDMAN, JM ;
JEFFERSON, JW ;
JOHNSON, EM ;
WEINER, ML .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (02) :146-150